Balanced news tone
News Sentiment
IPD sentiment intelligence
ImpediMed Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
87/100 classification confidence.
directly relevant articles
high-authority source matches
-8.3% over one week, -8.3% over four weeks, trend inactive, and below fair value.
IPD Group (ASX:IPG) Slips as Industrial Growth Stocks Take a Breather
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
IPD Group (ASX:IPG) Slips as Industrial Growth Stocks Take a Breather
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Jul 2026 13:17
- Source
- Kalkine
Impedimed Ltd (IPD) Stock Forum and Discussion
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 16:50
- Source
- Moomoo
ImpediMed Director Christine Emmanuel-Donnelly Increases Stake Through Share Issue
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 03 Jul 2026 11:45
- Source
- Kalkine
ImpediMed Cancels Over 20 Million Options and Performance Rights After Conditions Go Unmet
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Kalkine
ImpediMed Issues 2.69 Million Shares to Non-Executive Directors Under Fee-for-Equity Plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Kalkine
ImpediMed (ASX:IPD): Why Has This Healthcare Stock Suddenly Grabbed Attention?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jun 2026 07:00
- Source
- Kalkine Media
Fiona Bones Bought 911% More Shares In ImpediMed
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jun 2026 07:00
- Source
- simplywall.st
ImpediMed (ASX:IPD) Advances Funding Plans with Successful Share Purchase Plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Kalkine
ImpediMed (ASX:IPD) Gains as After Reporting Encouraging Sales Momentum and Pipeline Growth
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Kalkine
ASX 300 ImpediMed Trading Halt Signals Market Activity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- Kalkine Media
Impedimed (ASX:IPD) Falls Amid Investor Caution Around Small-Cap Healthcare Plays
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 09 Apr 2026 07:00
- Source
- Kalkine
What’s Holding Back ImpediMed (ASX: IPD) Despite FDA-Cleared Technology?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Mar 2026 07:00
- Source
- Kalkine
IPD Group (ASX:IPG) Margin Slippage Tests Bullish Earnings Growth Narrative
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 24 Feb 2026 08:00
- Source
- simplywall.st
Here's Why We Think IPD Group (ASX:IPG) Is Well Worth Watching
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Feb 2026 08:00
- Source
- Market source
IPD Group And 2 Other ASX Penny Stocks To Watch
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jan 2026 08:00
- Source
- simplywall.st
Australian Shares Flat; IPD Group to Acquire Cable Products Provider in Cash, Stock Deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 29 Dec 2025 08:00
- Source
- Market source
ImpediMed Limited's (ASX:IPD) Profit Outlook
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 27 Nov 2025 08:00
- Source
- Market source
IPD Group Limited's (ASX:IPG) top owners are individual investors with 41% stake, while 33% is held by institutions
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 02 Nov 2025 07:00
- Source
- Market source
ImpediMed accelerates growth strategy on strong results and expanding market reach
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 22 Oct 2025 07:00
- Source
- BiotechDispatch
Why IPD Group Limited (ASX:IPG) Could Be Worth Watching
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Oct 2025 07:00
- Source
- simplywall.st
Investors in ImpediMed (ASX:IPD) have unfortunately lost 37% over the last three years
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Aug 2025 07:00
- Source
- simplywall.st
ImpediMed (ASX:IPD) shareholders have endured a 48% loss from investing in the stock five years ago
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 13 Aug 2025 07:00
- Source
- Market source
IPD Stock Price and Chart — ASX:IPD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jul 2023 07:00
- Source
- TradingView
ImpediMed Limited (ASX: IPD) - Share Price
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Feb 2020 05:53
- Source
- intelligentinvestor.com.au
ImpediMed Limited (ASX: IPD) - Announcements
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Sep 2019 09:26
- Source
- intelligentinvestor.com.au
ImpediMed Limited (ASX:IPD)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Sep 2019 11:14
- Source
- intelligentinvestor.com.au
ImpediMed Limited director acquires shares on market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 May 2013 07:00
- Source
- Proactive financial news